Similarly, the 32 melanoma patients treated with PD1 inhibitor with high TMEscore had significantly better PFS than other patients (P = 0.045, HR = 2.89, CI = [1.11, 9.41], Figure 6G), while OS had no statistical difference (Figure 6F). The gene discussed is PDCD1; the disease is melanoma.